Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Researchers found a way to make rat hair follicle cells start turning into motor neuron-like cells, but couldn't fully turn them into working motor neurons.

Neurosteroids may help treat disorders with too much dopamine activity.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Cellular senescence may play a role in ALS, and anti-senescence therapies could be a promising treatment.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.

Deleting the PTEN gene in mice causes nerve cells to grow larger and heal better after injury, but may cause overgrowth and hair loss in older mice.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Sodium metasilicate improved spinal motoneuron recovery after sciatic nerve injury in rats.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Androgens help motor neurons grow by increasing neuritin.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Scientists created hair-growing skin models from stem cells, which could help treat hair loss and skin diseases.

Formononetin may help protect the brain and treat neurological diseases.

lncRNAs are important for understanding and treating skin diseases.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Dopaminergic neurons in the gut have distinct subtypes, some releasing both dopamine and acetylcholine.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.